KLYV THERAPEUTICS AS
Signals
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−1,1 mill kr).
- Nylig endring 2026-04-20 Aksjekapital registrert 2026-04-20.
KLYV THERAPEUTICS AS is registered as a limited company in Oslo, Oslo with organisation number 832316032. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2023. Registered share capital is NOK 122,000, divided into 121816 shares. The company's stated purpose is: “Utvikle og investere i legemidler, legemiddelkandidater, hjelpemidler, verktøy og metoder for pasientbehandling og persontilpasset medisin.”. The most recent filed accounts, for the 2025 financial year, show NOK 2.2m in revenue and NOK −1.1m in operating profit.
Key figures · 2025
Financial health · 2025
Who owns KLYV THERAPEUTICS AS?
KLYV THERAPEUTICS AS has 5 registered shareholders:
- SPRINGHEART HOLDING AS 77.5%
- TAILORMADE INVEST AS 19.8%
- PRECO AS 1.4%
- BERET LUISE SUNDET 0.6%
- ALEFA AS 0.6%
Frequently asked questions about KLYV THERAPEUTICS AS
Who owns KLYV THERAPEUTICS AS?
SPRINGHEART HOLDING AS is the largest registered owner, with 77.5%.
What is the revenue of KLYV THERAPEUTICS AS?
KLYV THERAPEUTICS AS had revenue of NOK 2.2m in 2025.
Who is the general manager of KLYV THERAPEUTICS AS?
Maria Vistnes is registered as general manager of KLYV THERAPEUTICS AS.
Where is KLYV THERAPEUTICS AS based?
KLYV THERAPEUTICS AS has its business address in Oslo.
Property
292 companies are registered at this address.
The address this company is registered at, from the company register and matched against the cadastre. It does not say who owns the property — a company may be a tenant, and the address is often its accountant's. Source: Brønnøysundregistrene and © Kartverket.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.